MindMed IPO on Nasdaq: Becomes Second Public Psychedelic Company
The MindMed IPO is exciting. It’s the second psycedelic company to trade on the U.S. market. Here’s what we know about the MindMed stock Nasdaq debut.
The MindMed IPO is exciting. It’s the second psycedelic company to trade on the U.S. market. Here’s what we know about the MindMed stock Nasdaq debut.